1. Home
  2. RVT vs LQDA Comparison

RVT vs LQDA Comparison

Compare RVT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVT
  • LQDA
  • Stock Information
  • Founded
  • RVT 1986
  • LQDA 2004
  • Country
  • RVT United States
  • LQDA United States
  • Employees
  • RVT N/A
  • LQDA N/A
  • Industry
  • RVT Trusts Except Educational Religious and Charitable
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVT Finance
  • LQDA Health Care
  • Exchange
  • RVT Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • RVT 1.9B
  • LQDA 1.9B
  • IPO Year
  • RVT N/A
  • LQDA 2018
  • Fundamental
  • Price
  • RVT N/A
  • LQDA $24.08
  • Analyst Decision
  • RVT
  • LQDA Strong Buy
  • Analyst Count
  • RVT 0
  • LQDA 9
  • Target Price
  • RVT N/A
  • LQDA $32.67
  • AVG Volume (30 Days)
  • RVT 243.4K
  • LQDA 2.9M
  • Earning Date
  • RVT 01-01-0001
  • LQDA 11-12-2025
  • Dividend Yield
  • RVT 7.32%
  • LQDA N/A
  • EPS Growth
  • RVT N/A
  • LQDA N/A
  • EPS
  • RVT 2.95
  • LQDA N/A
  • Revenue
  • RVT N/A
  • LQDA $19,322,000.00
  • Revenue This Year
  • RVT N/A
  • LQDA $405.58
  • Revenue Next Year
  • RVT N/A
  • LQDA $373.93
  • P/E Ratio
  • RVT $4.98
  • LQDA N/A
  • Revenue Growth
  • RVT N/A
  • LQDA 30.20
  • 52 Week Low
  • RVT $11.85
  • LQDA $9.71
  • 52 Week High
  • RVT $14.93
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • RVT 57.99
  • LQDA 52.50
  • Support Level
  • RVT $16.20
  • LQDA $21.35
  • Resistance Level
  • RVT $16.48
  • LQDA $23.33
  • Average True Range (ATR)
  • RVT 0.19
  • LQDA 1.18
  • MACD
  • RVT -0.02
  • LQDA 0.05
  • Stochastic Oscillator
  • RVT 59.26
  • LQDA 83.30

About RVT Royce Value Trust Inc.

Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements. The company invests in Industrials, Financials, Information Technology, Materials, Health Care, Communication Services, Real Estate and others.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: